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Abstract
Plants belonging to the genus Veratrum have been used throughout history for their medicinal 
properties. During the 19th and 20th centuries, phytochemical investigations revealed a host of 
steroidal alkaloids in Veratrum species, some of which are potent bioactives. This review 
discusses Veratrum species that grow in North America with a focus on the medicinal history 
of these plants and the steroidal alkaloids they contain. While significant reviews have been 
devoted to singularly describing the plant species within the genus Veratrum (botany), the 
staggering breadth of alkaloids isolated from these and related plants (phytochemistry), and the 
intricacies of how the various alkaloids act on their biological targets (physiology and
biochemistry), this review will straddle the margins of the aforementioned disciplines in an 
attempt to provide a unified, coherent picture of the Veratrum plants of North America and the 
medicinal uses of their bioactive steroidal alkaloids.
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Abbreviations:
USDA United States Department of Agriculture
NRCS National Resources Conservation Service, formerly the U.S. Soil Conservation Service
IUPAC International Union of Pure and Applied Chemistry
HPE Holoprosencephalopathy, a developmental abnormality in which the prosencephalon of the 
embryo fails to divide into separate hemispheres causing defects in facial and brain 
structures
Hh Hedgehog, used in reference to the complete series of biochemical events and structures 
that make up the embryonic hedgehog signaling pathway
hh Invertebrate hedgehog gene, originally discovered in Drosophila 
shh Vertebrate Sonic hedgehog gene
ihh Vertebrate Indian hedgehog gene
dhh Vertebrate Desert hedgehog gene
Shh Sonic hedgehog protein, potent morphogen coded for by shh
Shh-Np Active Sonic hedgehog protein, 19 kDa N-terminal fragment produced by autolytic 
cleavage of Shh and subsequent palmitoylation of the N-terminus and addition of 
cholesterol to the C-terminus
Ptch Patched, a twelve pass transmembrane transport protein integral to the hedgehog signaling 
pathway which serves as the binding site for the active Sonic hedgehog protein and 
regulates the activity of Smoothened
Smo Smoothened, a seven transmembrane G-protein like receptor integral to the hedgehog 
signaling pathway; initiates the signaling cascade regulating the activity of Gli transcription 
factors
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NBCCS Nevoid basal cell carcinoma syndrome, an autosomal-dominant inherited condition 
characterized by craniofacial malformations, spina bifida, and polydactylism in addition to 
high rates of basal cell carcinoma and cancers of the heart, ovaries, skin, and central 
nervous system
BCC Basal cell carcinoma, most common non-melanoma skin cancer; characterized by 
uncontrolled growth of cells in the stratum basale, the skin’s lowest layer
PNET Primitive neuroectodermal tumor, tumors originating in cells derived from the 
neuroectoderm such as medulloblastomas
KAAD-cyclopamine 3-keto N-aminoethyl aminocaproyl dihydrocin-namoyl cyclopamine, a potent hedgehog 
pathway antagonist derived from the natural product cyclopamine
CSC Cancer stem cell, highly proliferative undifferentiated tumor cells, which give rise to 
rapidly dividing “bulk” tumor cells
Introduction: A Botanical Overview of the Genus Veratrum
Veratrum is a genus of perennial flowering herbs of the Liliacea or Melanthiacea family, depending on taxonomic 
treatment, that are typically found in woodland or alpine areas and confined to the Northern hemisphere (Zomlefer 
et al. 2003). Plants of the genus Veratrum are widespread, with 17-45 distinct species, the bulk of which are native to 
Eastern Asia, the genus’s likely origin (Liao et al. 2007; Trier 2011). Eleven Veratrum species are endemic to North 
America (Liao et al. 2007; USDA NRCS 2013). Veratrum plants have a long and storied history of medicinal use, 
the foundation of which rests on a diverse spectrum of steroidal alkaloids produced by members of this genus.
Over the past century investigators have uncovered more than 100 distinct steroidal alkaloids in Veratrum plants (see 
reviews by Kupchan 1961; Tomko and Votický 1973; Atta-Ur-Rahman and Choudhary 1998; and Li et al. 2006), 
some of which are potent bioactives. This review focuses only on the species of Veratrum found in North America 
with an emphasis on the various bioactive steroidal alkaloids they contain. First, the distinct species of Veratrum
plants in North America will be covered, including their range, growing conditions, and alkaloids isolated from 
each. Second, the use of Veratrum alkaloids as therapeutic agents for hypertension in the mid-1900s will be 
surveyed. Lastly, the discovery of teratogenic Veratrum alkaloids and recent interest in the jervanine alkaloid 
cyclopamine as a model antagonist of the embryonic Hedgehog signaling pathway will be discussed.
North American Veratrum Species
Liao and colleagues encapsulate the complex taxonomy of Veratrum species very well in their 2007 study of flower
color in the genus, stating, “The number of species depends largely on taxonomic treatment of four widely spread 
species complexes, viz V. album L., V. nigrum L, V. maackii Regal from Eurasia and V. viride Aiton from North 
America” (pp 177). Indeed, it is quite difficult to categorize Veratrum species purely on morphological features as 
these can exhibit distinct local variation, with different species grading into one another geographically (for 
example, V. oxysepalum and V. grandiflorum, members of the genetically assigned V. album complex, have been 
traditionally defined along an arbitrary north/south division in Japan and Korea, see Kupchan 1961 and Zomlefer et 
al. 2003). In deciding which North American species to include and discuss, we have relied on Dr. Wendy 
Zomlefer’s 2003 phylogenetic analysis of Veratrum in addition to the United States Department of Agriculture’s 
(USDA) PLANTS database (Zomlefer 2003; USDA NRCS 2013). The overarching sections assigned by Dr. 
Zomlefer (2003) are used for organization. A graphic depiction of the distribution of Veratrum species in North 
America has been created (Figure 1). Details regarding each North American Veratrum species, including 
morphology, habitat, range and steroidal alkaloids have been included as a table in the appendix.
Zomlefer’s Section Veratrum [Clade B]
Veratrum plants typically have a long, thick rhizome featuring many smaller roots and capped by a bulb. Plants are 
tall (1-2 m) and feature a pseudostem formed by overlapping sheaths at the sessile base of broad oval to elliptical 
leaves, which extend up the stem to the inflorescences. Plants of this section have 32 chromosomes (Zomlefer et al. 
2003). North American species within section Veratrum are the primary focus of this review, as they have been 
investigated extensively for steroidal alkaloid content.
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Veratrum viride
Veratrum viride (green false hellebore) has a discontinuous geographical distribution, growing 
throughout eastern North America, from Quebec to Georgia, and is also found across the western 
margin of the continent from Alaska to California and inward to the mountainous regions of 
Montana, Idaho, and Alberta (Kupchan 1961; Zomlefer et al. 2003; USDA NRCS 2013). The 
species has been divided into two subspecies based on the east/west distribution (the western 
variety of V. viride was formerly considered the separate species V. eschoscholtzii; any data 
specific to this species will be grouped with V. viride for the purposes of this review) and may or 
may not be a variant that should be grouped in the V. album complex (Youngken 1952; Youngken 
1953; Kupchan 1961; Zomlefer et al. 2003; USDA NRCS 2013). V. viride spans a large variety of 
habitats from wet woods and moist coastal regions in Alaska and Quebec to mountain meadows in 
northern California, Idaho, Montana, and North Carolina. As is to be expected with such a 
widespread species, local morphological variations exist, but V. viride generally feature green 
perianths (Kupchan 1961).
Veratrum tenuipetalum
Veratrum tenuipetalum (Colorado false hellebore) is a species found primarily in Colorado and in 
the southern reaches of Carbon County, Wyoming, but is disputed taxonomically (Johnston 2002; 
USDA NRCS 2013). Unfortunately, this species has not been sampled for phylogenetic study. As a 
result, V. tenuipetalum A. Heller is often considered the same species as V. californicum var.
californicum, which grows outside of Colorado, based on morphology and ecological factors 
(Kupchan 1961; Johnston 2002; Iler and Inouye 2013). V. tenuipetalum is commonly found in 
subalpine meadows and aspen forests and can feature very large inflorescences (greater than 1.5 
m) which are studded by small white perianths (Iler and Inouye 2013).
Veratrum fimbriatum
Veratrum fimbriatum (fringed false hellebore) is confined to a narrow coastal strip of northern 
California between Fort Bragg and Fort Ross. V. fimbriatum is distinct from other North American 
members of the genus due to its narrow, low-elevation habitat (reported to extend only 5 km 
inward from the coastline and up a few hundred meters in elevation), heavily fringed tepals, and 
large wingless seeds (Taylor 1956a; Kupchan 1961; Zomlefer et al. 2003; USDA NRCS 2013).
Veratrum insolitum
Veratrum insolitum (Siskiyou false hellebore) is found primarily in northern California and 
southwestern Oregon with a small isolated population documented in southwestern Washington. V. 
insolitum features wooly, grey ovaries and inflorescences covered in small, white and fringed 
tepals. Notably, the species is often found growing in serpentine and diorite soils on mountain 
slopes, which stands in contrast to the stagnant wet conditions preferred by many other members 
of the genus (Kupchan 1961; Washington Department of Natural Resources 2003; Zomlefer et al. 
2003; USDA NRCS 2013).
Veratrum album
Veratrum album (white false hellebore) is a primary Veratrum species of Europe which “forms a 
complex of broad geographic clines to which there are many striking local exceptions in all 
regions” (Kupchan 1961, pp 8). V. album is often treated as a complex of species consisting of V. 
lobelianum, V. grandiflorum, and V. oxysepalum due to its widespread, variable nature.
Phylogenetic analyses of V. album populations in Europe strongly suggest the species entered 
Europe from the east, consistent with an ancient East Asian origin of the species and genus (Liao 
et al. 2007; Treier and Müller-Schärer 2011). V. album also expanded eastward, likely across the 
ancient Bering Land Bridge, and modern populations exist in Alaska (Treier and Müller-Schärer 
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2011; USDA NRCS 2013). Members of the V. album complex are generally identified by their 
large white tepals but local variations can include small green, white or even yellow tepals 
(Kupchan 1961; Zomlefer et al. 2003; USDA NRCS 2013).
Veratrum californicum
Veratrum californicum var. californicum (Californica false hellebore) is found in the American 
west, particularly in high meadows of Idaho, Oregon, Utah, California, and New Mexico 
(Kupchan 1961; USDA NRCS 2013). The species prefers moist, subalpine mountain 
environments, typically in areas that receive significant snowpack during the winter months which 
contribute to the chilling required to break dormancy as well as early season moisture (Sun et al. 
2012; Doniger and Shock 2011). V. californicum has unique soil requirements, growing naturally 
in acidic (pH 6.3) sandy loams that are high in calcium and iron (Shock and Shock, 2011). V. 
californicum has large, heavily flowered inflorescences that feature broad white tepals (Kupchan
1961).
Veratrum californicum var. caudatum (Cascade false hellebore) can be found at lower elevations 
from north central Idaho to the coastal mountains of Washington and Oregon (Kupchan 1961; 
USDA NRCS 2013). V. californicum var. caudatum features a notable unbranched extension of the 
main stem which is studded with large, green to white perianths during flowering (Kupchan 1961).
Zomlefer’s Section Fuscoveratrum [Clade C]
Fuscoveratrum plants tend to feature slender leaves that are located at the base and a very small to non-existent 
rhizome. Tepals are often conspicuously clawed. Plants of section Fuscoveratrum have 16 chromosomes (Zomlefer 
et al. 2003).
Veratrum latifolium, virginicum, woodii, hybridum and parviflorum are circumscribed within the genus 
Veratrum and can be found in the south and east of North America (Zomlefer et al. 2003). These plants 
have been categorized as a separate genus Melanthium at different points in time based on their distinct 
morphological characteristics, such as narrow petiloate leaves and clawed tepals which stand in contrast to 
the broad sessile leaves and unclawed tepals of other North American Veratrum species, such as V. viride or 
V. californicum (Zomlefer et al. 2001; Zomlefer 2003). Yet, phylogenetic analyses of the internal 
transcribed spacer region of nuclear ribosomal DNA of different Veratrum plants placed these four species 
as a subsect of the genus Veratrum, albeit in the distinct Fuscoveratrum section (Zomlefer et al. 2001; 
Zomlefer et al. 2003). Veratrum species of section Fuscoveratrum have not been the subject of 
phytochemical investigation focused on steroidal alkaloids, thus there will not be further discussion of these 
species in this review.
Veratrum Alkaloid Overview and Biosynthesis
IUPAC formally defines alkaloids as, “Basic nitrogen compounds (mostly heterocyclic) occurring mostly in the 
plant kingdom (but not excluding those of animal origin),” excluding amino acids, peptides, proteins, nucleotides, 
nucleic acids, amino sugars and antibiotics (IUPAC 2006). However, a more serviceable definition comes courtesy 
of Pelletier (1983), in which he states, “An alkaloid is a cyclic organic compound containing nitrogen in a negative 
oxidation state which is of limited distribution among living organisms” (pp 26). Of this wide reaching class of 
chemical compounds, steroidal alkaloids are a subset defined by the presence of a steroidal 
(cyclopentanophenanthrene or derivative) skeleton with a nitrogen atom either as an integral part of the molecule or 
as a side chain. Notably, steroidal alkaloids are not derived from amino acids but instead find their roots in steroids 
or triterpenoids. Due to similarities with endogenous steroids in the body (corticosteroids, hormones, anabolic 
steroids), steroidal alkaloids have been a major subject of pharmacological investigation (Atta-ur-Rahman and 
Choudhary 1998).
Among the many different steroidal alkaloids that exist in nature, two broad groups have been isolated from 
Veratrum species: those featuring the typical cyclopentanophenanthrene skeleton of cholesterol (sometimes referred 
to as the Solanum alkaloids) and those which have a C-nor-D-homosteroidal skeleton featuring a five-membered C-
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ring formed through bond migration from C-12 to C-13 via a Wagner-Meerwan rearrangement mechanism (Figure 
2) (Hirschman et al. 1954; Mitsuhashi and Shimizu 1963). Alkaloids of this latter group are commonly referred to as 
Veratrum alkaloids and were some of the first steroidal alkaloids known to science (Li et al. 2006; Meissner 1819). 
In fact, the term “alkaloid” was coined in 1819 by German pharmacist Wilhelm Meissner in his description of what 
is now known to have been a mixture of Veratrum alkaloids isolated from the related plant Schoenocaulon officiale 
(sabadilla or cevadilla), which is native to Mexico and was brought back to Europe in the late 1500s (Meissner 
1819; also Wood 1856, Pelletier 1983; Zomlefer et al. 2006).
Within the Solanum alkaloids, two further classes are evident, those of the verazine type featuring a distinct imine 
containing ring and those of the solanidine type in which the nitrogen containing ring has become fused to the rest of 
the cyclic system. This has been hypothesized to happen through the nucleophilic attack of the lone pair of electrons 
on the nitrogen atom to a suitable electophilic atom containing a good leaving group on the D-ring, to form a tertiary 
amine (Kaneko et al. 1977). The Veratrum alkaloids can also be further divided into distinct structural groups: the 
veratranine, jervanine, and cevanine types. The veratranine group is defined by the presence of an aromatic D-ring, 
whereas alkaloids of the jervanine type feature a tetrahydrofuran E-ring linking the amine containing F-ring to the 
D-ring through a spiroconnection at C-17. Cevanine alkaloids are distinct from the other two classes of Veratrum 
alkaloids in that they have a six-membered E-ring hypothesized to form through nucleophilic attack of the nitrogen 
in the piperidine ring on a neighboring methyl that has a suitable leaving group (such as a phosphate group) (Kaneko 
et al. 1978; Kaneko et al. 1979). Cevanine alkaloids are highly hydroxylated in Veratrum plants, with 7 to 9 atoms of 
?????????????????????-ketol and hemiketal linkages between C-4 and C-9 of the A and B rings respectively (Krayer 
and Meilman 1977; Kaneko et al. 1970a). While many genera in Liliaceae produce steroidal alkaloids, some 
chemotaxanomic distinctions can be drawn. Cevanine alkaloids of the 4,9-olide and ester types are common in 
Veratrum, Zigadenus, and Schoenocaulon but in Fritillaria????-cevanine steroidal alkaloids are common (Li et al. 
2006). Of the Veratrum alkaloids, those of the cevanine and jervanine types have garnered the most medical 
attention as therapeutics for their action as hypotensive and chemotherapeutic agents respectively.
As may be surmised from the structural similarities between the Solanum and Veratrum alkaloids, the two classes 
share a biosynthetic pathway, which has been partially investigated (Figure 3). What is known about the 
biosynthesis of Veratrum alkaloids comes from work using radiolabeled carbon isotopes in V. grandiflorium (part of 
the V. album complex) by Kaneko and colleagues in the 1970s (Kaneko et al. 1970a, b; 1972; 1975-1979). By 
administering acetate-1-14C and cholesterol-4-14C to V. album and measuring the incorporation of these radioisotopes 
into the alkaloids jervine and veratramine, Kaneko and colleagues discovered that the synthesis of steroidal alkaloids 
in Veratrum likely begins with acetate which is transformed into cholesterol through the mevalonate pathway 
(Kaneko et al. 1970a, b). Cholesterol then undergoes a series of oxidations, reductions, and rearrangements that 
build on the cyclopentanophenanthrene steroidal scaffold to produce the different classes of steroidal alkaloids.
Kaneko and colleagues elucidated four important parts of the biosynthetic pathway for Veratrum alkaloids. First, the 
source of nitrogen for the piperidine ring (this appears in the biosynthetic pathway as verazine) is likely L-arginine 
(discovered using the 15N-labelled amino acid), which accumulates in the dormant rhizome prior to budding (Figure 
3a) (Kaneko et al. 1976). Second, the conversion of solanidine to the Veratrum type alkaloids, which feature a C-
nor-D-homosteroidal skeleton, is light dependent and indicates that the Wagner-Meerwan type rearrangement of 
epirubijervine likely requires the input of ATP (Figure 3b) (Kaneko et al. 1972; 1979; Heretsch et al. 2010). Third, 
the isolation of the intermediate compound procevine suggests that cevanine-type alkaloids are formed by 
nucleophilic attack from the nitrogen lone pair electrons of the piperidine ring to a suitable electrophilic atom 
containing a good leaving group attached to C-18 of isorubijervine, prior to rearrangement to the C-nor-D-
homosteroidal skeleton (Figure 3c) (Kaneko et al. 1978; 1979). Lastly, Kaneko et al. discovered a common 
precursor to both the veratranine and jervanine type alkaloids when administration of jervine to plants being fed 
radioactive acetate led to the production of radioactive veratramine at the expense of radioactive jervine. This result 
suggested an allosteric model of inhibition at the site of synthesis for the two compounds (Kaneko et al. 1970a). 
Kaneko et al. found cyclopamine (11-deoxojervine) to be a possible precursor after radioactive cyclopamine fed to 
cultivated V. grandiflorum plants produced both radioactive jervine and veratramine, 26.1% and 12.1% respectively 
(Figure 3d). The low rate of veratramine synthesis from cyclopamine suggests the possibility of additional synthetic 
routes for this alkaloid that precede the formation of cyclopamine and jervine, but no published work has addressed 
what these may be (Kaneko et al. 1970b).
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Early Medicinal Use of Veratrum Plants
The powerful physiological effects of Veratrum did not go unnoticed by early peoples and the plants were variously 
regarded as medicine or poison. Considering that the epicenter of the genus’s diversity is in eastern Asia, it is not 
surprising that rhizome and root material of Veratrum plants are prominent in Chinese medicine, referred to as “Li-
lu,” and has been used for centuries (Li et al. 2006). Similarly, certain western Native American tribes, such as the 
Shoshone, used Veratrum medicinally, applying the crushed rhizome of V. viride to snake bite wounds, using a tea to 
treat veneareal diseases, and chewing the raw root to help with sore throats and colds (Sweet 1976). The rhizome of 
V. viride was also used in a qualification test by some Native American tribes in northeast North America; the man 
who could best withstand its emetic properties upon ingestion was judged to have the strength to be the group’s 
leader (Osgood 1835). V. album, a common Veratrum species in Europe, has a long history of medicinal use, dating 
back as far as Hippocrates in which dilutions of the plant are prescribed to produce upward purging (Adams 1886). 
Gerard wrote of V. album’s (white hellebore) emetic effects with particular poignancy in his influential 1633 treatise 
The Herbal or General History of Plants, reporting that “root of white Hellebor procureth vomite mightly, wherein 
consisteth his chiefe virtue, and by that means voideth all superfluous slime and naughtie humours” (pp 441). 
Through the 1700s, preparations of V. album root and rhizomes were used medicinally in Europe primarily for their 
emetic properties. It wasn’t until the discovery of the first pure alkaloids (e.g. morphine in 1805 and quinine in 
1817) and the pursuit of “vegetable chemistry” came into being that chemical investigation of Veratrum plants was 
first attempted (Mathew 1989; Pelletier 1983).
19th Century Use of Veratrum plants and Early Phytochemistry
The first isolation of Veratrum (and quite possibly steroidal) alkaloids was accomplished by the German pharmacist 
Wilhelm Meissner in 1819 from the seeds of S. officiale (as mentioned above). Concurrently, French researchers 
Pelletier and Caventou were also investigating the extracts of S. officiale seeds and obtained a substance, to which 
they gave the name veratrine, much like the dirty-white colored solid isolated by Meissner. While stymied in their 
attempts to characterize the substance as either acid or base (possibly due to the resulting hydrolysis of the esterified 
carboxylic acid moieties from the steroidal backbone which masked the alkaline nature of the parent molecule) they 
found it to act similarly to morphine and strychnine when subjected to concentrated nitric acid, producing a blood 
red color. Alongside their experiments with veratrine, Pelletier and Caventou published the first chemical 
investigation of steroidal alkaloids isolated from the rhizome V. album, noting that the resulting substance differed 
little from that obtained from S. officiale seeds (Pelletier and Caventou 1820). It is now known that the likely 
compounds in the veratrine isolated by Pelletier and Caventou were cevadine and veratridine, C-3 esters of 
veracevine, while those from V. album were likely polyallylic esters of germine, protoverine, and zygadenine 
(Krayer and Meilman 1977).
At the same time Pelletier and Caventou were investigating the extracts of V. album, their contemporaries in 
America had noted the similarities in appearance and medicinal qualities between the white hellebore (V. album)
common in Europe and their own American or green hellebore (V. viride). The first account of V. viride’s use in the 
medical literature is from 1835, in which Dr. Charles Osgood described the plant’s physiological effects upon 
ingestion as well as a chemical investigation of the rhizome resulting in a product “thrown down” by ammonia that 
was of “a clear white colour, pulverulent, inodorous, and very acrid, producing a peculiar stinging sensation when 
taken upon the tongue” (Osgood 1835, pp 295). Dr. Osgood’s description of his product is similar to veratrine and he 
mentions that it was commonly believed that the active principle of V. viride was identical to that of veratrine 
(Osgood 1835; Wormley 1876). Dr. Osgood recommended that V. viride be used as a treatment for inflammatory 
diseases and rheumatism, as it reduced the frequency and strength of the pulse (Osgood 1835).
While Dr. Osgood brought V. viride to the attention of the medical community for the first time, it wasn’t until Dr. 
Wesley C. Norwood of Cokesbury, South Carolina, began producing and bottling a tincture of the rhizome in the 
1850s that this crude extract of mixed steroidal alkaloids came into wider use (“Norwood’s Tincture” was made by 
macerating eight ounces of the dried rhizome in a pint of officinal alcohol, 90-95% ethanol, for two weeks) (Wood 
1856). Eventually, production of this tincture was taken over by a branch of the religious group the Shakers, and it 
was distributed widely in the central and western parts of the United States (Rhame 1957; Estes 1992). With its 
growing medical footprint, the extract won both loyal supporters and detractors (Rhame 1957). The latter considered 
the extract to a be a dangerous remedy due to its ability to induce striking bradycardia and apnea, forceful vomiting, 
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and sedation to the point of collapse when administered as directed on Norwood’s vials (Baker 1859). Those who 
adjusted Norwood’s dosage to more manageable levels, such as Dr. Paul Baker of Augusta, Georgia, became 
advocates of its use in just about every situation from epilepsy to pneumonia (Baker 1859; Rhame 1957).
…for, always let it be remembered and never forgotten, that Veratrum viride controls the circulation by its 
sedative influence upon those nerves whose ‘abberated action’ forces the heart and arteries into such an 
unnatural and dangerous turmoil (Baker 1859, pp 580)
Though early medical practitioners were quite perceptive in their analysis of the gross affects V. viride extracts had 
on the nervous and circulatory system, it wasn’t until a decade later that insight into the underlying mechanism of 
action of cevanine ester-alkaloids in the body started to come to light.
Physiology of the Hypotensive Response Caused by Cevanine Ester-Alkaloids
In 1867, German physiologists Albert von Bezold and Ludwig Hirt were investigating the action of veratrine on the 
heart when they observed that the sudden hypotension and bradycardia after administration of this mixed alkaloid 
extract could be relieved by severing the vagus nerve. von Bezold and Hirt assumed this effect resulted from 
stimulation of sensory nerves on the inner surface of the heart which then inhibited the vasomotor center leading to 
peripheral vasodilation (von Bezold and Hirt 1867). This conclusion did not go unchallenged and the mechanism 
behind the vasodepressive response caused by veratrine was a source of controversy in the field of cardiac 
physiology for the following sixty years (see the review by Krayer and Meilman 1977 for an excellent early history). 
Finally, in 1939, the Austrian team of Jarisch and Richter (1939a, b) unequivocally confirmed von Bezold and Hirt’s 
hypothesis that the bradycardia and hypotension caused by veratrine were the result of reflex action originating in 
the ventricles of the heart and transmitted via the afferent and efferent pathway of the vagus nerves (Krayer 1961; 
Aviado and Aviado 2001). The triad of bradycardia, hypotension, and apnea observed upon administration of 
cevanine ester-alkaloids is now known as the Bezold-Jarisch reflex (Aviado and Aviado 2001).
Subsequent investigations revealed that reflex vasodepression and cardiodecelerator effects caused by certain 
cevanine-ester alkaloids do not depend solely on receptors in the heart, but are the result of nonspecific stimulation 
of mechanoreceptors located throughout the circulatory system, including the aorta, carotid sinus, and pulmonary 
vascular bed (Krayer 1961; Krayer and Meilman 1977; Aviado and Aviado 2001).  The specific mechanism of this 
stimulation lies in the ability of hypotensive cevanine ester alkaloids, such as veratridine, cevadine and 
protoveratrines A and B, to bind to voltage-gated sodium channels in cells which feature excitable membranes such 
as nerves, skeletal muscles, and cardiac cells (Krayer and Mendez 1942; Honerjäger et al. 1982; Ulbricht 1998). 
Upon alkaloid binding, the sodium channel remains in an open state, creating a positive inotropic effect which 
delays repolarization of the cellular membrane and causes multiple discharges from each neuronal stimulus (Nánási 
et al. 1990; Wang and Wang 2003). The hypotensive cevanine-ester alkaloids bind to the sixth transmembrane 
segment of the second homologous domain (D2-???????????????-subunit in the voltage-gated sodium channel (type 2 
receptor site); this binding is readily reversible, which explains the relatively short duration of the bradycardic and 
hypotensive effects (Meilman 1956; Meilman and Krayer 1977; Wang and Wang 2003). While all electrical cells are 
subject to the positive inotropic effects of hypotensive cevanine-ester alkaloids, the cardiac cells and 
mechanoreceptors in the left-ventricle of the heart play an important role in the Bezold-Jarisch reflex, which is a 
specific manifestation of the left-ventricle mechanoreceptor reflex. Under normal physiological conditions, the left-
ventricle mechanoreceptor reflex continually coordinates peripheral resistance with myocardial contractility so as to 
keep arterial pressure constant, but hypotensive cevanine ester alkaloids cause myocardial contractility to increase 
due to their positive inotropic effects, thus causing peripheral resistance and blood pressure to decrease (Estrin et al. 
1979).
Modern Phytochemistry and Use of Veratrum Alkaloids in the Treatment of Hypertension
Phytochemical understanding of Veratrum alkaloids expanded rapidly in the early 20th century due to advances in 
separation techniques. Though late 19th century researchers Mitchell (Wormley 1876), Wright and Luff (1879; 
Wright 1879), and Salzberger (1890) obtained amorphous alkaloid resins from V. album and V. viride, the German 
investigator W. Poethke was the first modern chemist to successfully purify Veratrum alkaloids of the cevanine 
type1,2, procuring the ester alkaloids protoveratrine and germerine in addition to the alkamines germine and 
protoverine from the rhizomes of V. album in 1937 (Poethke 1937a, b). Poethke’s work caught the attention of 
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researchers Lyman Craig and Walter Jacobs at the Rockefeller Institute for Medical Research in New York City, 
New York, who had been working on the degradation of the related alkaloid veracevine (the alkamine base of the 
ester alkaloids found in veratrine obtained from the seeds of S. officiale). Craig and Jacobs subsequently shifted their 
focus to the alkaloids of the native V. viride, the American or green false hellebore.
During the course of their investigations on Veratrum alkaloids (of which there were many, the reader is directed to 
the full series “The Veratrine Alkaloids” beginning in 1937 and ending in 1956), Craig, Jacobs, and colleagues found 
Poethke’s germine to be an isomeric form of the compound veracevine, the esters of which were utilized for their 
hypotensive properties by Jarisch and Richter in their investigations of cardiac reflexes (see above) (Craig and 
Jacobs 1943a; Jarisch and Richter 1939a, b). Similarly, protoverine (the alkamine of protoveratrine) was found to be 
a 27-carbon base that behaved similar to veracevine and germine (Jacobs and Craig 1943; Craig and Jacobs 1943b). 
These correlations were some of the first chemical evidence hinting at the hypotensive underpinnings of Veratrum 
extracts. Though not identical to the principle components of veratrine (as hypothesized over 100 years before, see 
Osgood 1835), the ester alkaloids in Veratrum species were conspicuously close; trials of veratrine to treat 
hypertension had already begun and testing pure Veratrum alkaloids in a similar manner was a logical next step 
(Krayer and Mendez 1942; Krayer et al. 1944).
The renewed interest in Veratrum alkaloids in the 1940s came at a lull in their medicinal use; Veratrum extracts had 
largely fallen out of favor by the early 20th century due to difficulties with dosing, a result of the variable 
composition of the mixed alkaloid extracts (Meilman and Krayer 1950). One use for Veratrum extracts that persisted 
was in the treatment of eclampsia (Bryant and Flemming 1940). A mixed alkaloid extract of V. viride, Veratrone, was 
marketed to physicians in the early 20th century for use in obstetric emergencies (Hawes 1917). However, when 
chemists such as Poethke, Craig, Jacobs, and others developed methods to obtain pure alkaloids from Veratrum 
plants, medical researchers seized the opportunity to test these alkaloids as hypotensive agents in isolation rather 
than as variable mixtures.
One of the first alkaloids evaluated in this manner was protoveratrine, a principle alkaloid from V. album (first 
isolated by Salzberger in 1890 and later purified by Poethke, Craig and Jacobs). Krayer and colleagues demonstrated 
that protoveratrine could be used as a hypotensive agent, first in animal models and then in human trials, and in 
dosages that limited toxic effects (Krayer et al. 1944; Meilman and Krayer 1950). Subsequent phytochemical 
analysis by numerous groups revealed that protoveratrine was actually a mixture of two tetraacyl esters of 
protoverine differing only at C-3 (Nash and Brooker 1953; Kupchan and Ayres 1960). Clinical studies with the two 
compounds advanced protoveratrine B as the preferred drug candidate as it had similar potency to protoveratrine A 
but fewer emetic side-effects (Winer 1960).
Whereas the protoveratrines were easily isolated from V. album, it was not until 1952 that this group of compounds, 
along with another ester, termed neoprotoveratrine, was identified in V. viride (Klohs et al. 1952). Rather, 
investigations by Fried and colleagues (1949; 1950) found that the principal alkaloids responsible for the 
hypotensive effects of V. viride were esters of germine, coined germidine and germitrine. Continuing purification of 
amorphous fractions from V. viride expanded the list of germine esters to include neogermitrine, germbudine and 
isogermbudine (Fried et al. 1952; Myers et al. 1952). As the search for Veratrum alkaloids expanded into species 
beyond V. viride and V. album, the last group of hypotensive ester alkaloids, those based on the alkamine 
zygadenine, were found in V. fimbriatum (Klohs et al. 1953). Vetroylzygadenine, the zygadenine ester isolated by 
Klohs et al. from V. fimbriatum, had previously only been isolated from Zigadenus venenosus (death camas) a 
related plant within the Liliacea family, blurring the chemotaxonomic lines separating these genera3 (see Figure 5
for an overview of cevanine ester-alkaloid bases) (Kupchan and Deliwala 1953).
The isolation of new hypotensive Veratrum alkaloids4 proceeded rapidly in the early 1950s, and researchers needed 
to assess the relative ability of these compounds to lower blood pressure before widespread clinical was feasible. As 
assessed in anesthetized dogs, the 3, 7, 15 triesters of germine (e.g. germitrine and neogermitrine) were found to be 
most potent, followed by the 3, 6, 7, 15 tetraesters of protoverine (e.g. protoveratrine A and B), then 3, 15 diesters of 
germine (germbudine and neogerbudine), and lastly vetroylzygadenine, a C-3 ester of zygadenine (reviewed in 
Kupchan 1961). With these data in hand, numerous pharmaceutical companies developed formulations of cevanine 
ester alkaloids, isolated from V. viride and V. album, for clinical use. Principle among these pharmaceutical products 
were a purified but crude mixture of polyacyl germine esters from V. viride that went by the trade names Veriloid 
(Riker Labs, now part of 3M), Vergitryl (E.R. Squibb & Sons), and Vertavis (Irwin, Neisler & Company) and a 
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mixture of protoveratrines A and B that were marketed under the names Provell maleate (Eli Lilly & Co.) and 
Veralba (Pittman Moore Company)(Grimson 1955). Demand was deemed high enough that initial investigations 
began into the cultivation of wild Veratrum plants, which proved to be a challenging endeavor due to their slow rate 
of growth, chilling requirements, and low germination rates (Taylor 1956b).
Compounding the difficulties encountered in obtaining a reliable supply of Veratrum alkaloids due to the fickle 
growing demands of the wild plants, the alkaloids had clinical limitations as well. For one, the reflex action (Bezold-
Jarisch reflex) responsible for the hypotensive effects of cevanine ester alkaloids was rapid in onset (minutes) but 
short lived in duration (less than three hours). This made Veratrum alkloids only suitable for control of hypertensive 
emergencies and limited their use in chronic hypertension (Fries and Stanton 1948; Meilman and Krayer 1950; 
Meilman 1956; Winer 1960; Page and Sidd 1972). Also, the narrow range between toxic and therapeutic dosages 
(approximately 30%) made titrating dosages in patients problematic, though the toxic effects could be rapidly 
reversed through the administration of atropine (Meilman 1956; Page and Sidd 1972). The emetic side effects once 
thought to be the result of impurities in the crude alkaloid extracts being used were found to be the result of 
stimulation of the nodose-ganglion and therefore intrinsic to the hypotensive alkaloids themselves. Toxic doses also 
produced feelings of epigastric and substernal oppression in addition to nausea, sweating, marked hypotension, 
bradycardia, heart block and even extrasystoles (Meilman 1956). Despite these limitations, hypotensive Veratrum 
alkaloids made their way into mainstream clinical use, and by 1973, more than one million prescriptions for extracts 
of V. viride had been written (Page and Sidd 1972; Farnsworth and Morris 1976). However, the use of V. viride
alkaloids was eventually abandoned as better-tolerated and more effective pharmaceutical agents such as 
methyldopa and diazoxide were developed to treat hypertensive emergencies (Page and Sidd 1972).
The Discovery of Teratogenic Veratrum Alkaloids
In the late 1950s, at the height of interest in hypotensive Veratrum alkaloids, sheep herders in the highlands of Idaho 
began to notice an unusually high rate of lambs being born with cyclopean-type malformations (a form of 
holoprosencephalopathy, HPE) and recruited investigators from the United States Department of Agriculture’s 
(USDA) Agricultural Research Service-Poisonous Plant Research Laboratory in Logan, Utah, to help solve the 
problem (Binns et al. 1962; James 1999). The investigators noted that all the affected ewes were newly pregnant and 
had been grazing in moist seepage meadows studded with stands of V. californicum.  After ruling out a possible 
genetic link, researchers recreated the cyclopean malformations through feeding trials with V. californicum, 
cementing the plant as the causal agent. Only ewes that fed on V. californicum between the second and third weeks 
of pregnancy, approximately the 14th day of gestation, were susceptible to the teratogen, suggesting interference with 
the development of the neural plate (Binns et al. 1962; Keeler and Binns 1964; Binns et al. 1965; James 1999; 
Gaffield 2000).
Consequently, the search for the causal agent turned toward Veratrum alkaloids. Researchers Richard Keeler and 
Wayne Binns proceeded to systematically test crude alkaloid fractions obtained from ethanol and benzene soaks of 
V. californicum biomass for their teratogenic potential in sheep. They ruled out the hydrophilic cevanine type ester 
alkaloids as both commercial preparations and fractions containing these compounds failed to produce teratogenic 
responses (Keeler and Binns 1966c). Keeler and Binns narrowed their search to fractions containing an unidentified 
glycoside (alkaloid X), an unidentified alkamine (alkaloid V), jervine, and veratrosine (Keeler and Binns 1964; 
1966b).  Notably, Keeler and Binns also isolated veratramine from V. californicum and found it (along with 
veratrosine) to cause teratogenic malformations in sheep, but these malformations were distinct from the cyclopia 
they set out to investigate, being characterized instead by hypermobility of the knee joints leading to bow-legged 
lambs unable to stand (Keeler and Binns 1964; 1966a; 1967).
Further chemical investigations revealed alkaloid V to be identical to 11-deoxojervine, first isolated by Masamune 
and colleagues from V. grandiflorum in 1965, and alkaloid X to be its C-3 glycoside (Keeler 1969a, b). Keeler 
assigned the trivial names cyclopamine and cycloposine, respectively, to these compounds in recognition of their 
teratogenic effects (Keeler 1968; Keeler 1969b). In the same time period, Keeler and Binns carried out definitive 
feeding trials in both ruminant (sheep) and non-ruminant animal models (rabbits) with purified steroidal alkaloids 
that established cyclopamine, cycloposine, and jervine as the compounds in V. californicum responsible for the 
cyclopean-malformations first observed over a decade earlier (Keeler and Binns 1968; Keeler 1970b; 1971a; James 
1999).
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In the course of their phytochemical search for the teratogenic agents in V. californicum, Keeler and Binns advanced 
knowledge of the steroidal alkaloids in North American Veratrum species greatly. Prior to their investigations, 
scientific work on Veratrum had focused on the hypotensive cevanine-type alkaloids at the expense of the free 
alkamine bases. Keeler and Binns not only identified a number of new compounds never before isolated from North 
American Veratrum species (cyclopamine, cycloposine, and muldamine), they identified an otherwise unknown 
physiological role of jervanine-type steroidal alkaloid compounds, that of vertebrate teratogen (Keeler 1978). 
Following the initial identification and structural elucidation of the jervanine-type steroidal alkaloids in V. 
californicum, Keeler and colleagues turned to the more difficult question of how these compounds interfere with 
proper fetal development.
Using derivative compounds and structurally related, non-teratogenic species, such as tomatidine, (Figure 5) in a 
hamster model Brown and Keeler were able to deduce a number of chemical features that affected teratogenicity of 
the jervanine steroidal alkaloids. Initial work suggested that only alkaloids with a rigid terminal furanopiperidine 
ring system, such as jervine and cyclopamine, produced teratogenic effects, possibly due to the positioning of the 
??????????? ?????????????????????????? ?????-side of the ring system (Keeler 1970a; 1971a; 1978; Keeler et al. 1976; 
Brown and Keeler 1978c). Additionally, large N-alkyl groups significantly reduced the teratogenicity of jervine 
derivatives whereas N-methyl and N-formyl derivatives remained relatively teratogenic, suggesting that both the 
steric and electronic state of the nitrogen atom were important for bonding at the active site (Brown and Keeler 
1978b, c). Another hypothesis, based on the potent cyclopamine derivative 11-deoxojervine-4-en-3-one, was that the 
unsaturation of the A-B ring system in the jervanine alkaloids, which is similar to endogenous steroids, might cause 
them to impair hormone function during embryogenesis (Keeler 1970a; Brown and Keeler 1978a). Later work 
substantiated this early observation, revealing that the relative unsaturation at C-5 and C-6 in steroidal alkaloids was 
more closely linked to incidence of cyclopean birth defects than the position or basicity of the nitrogen (Gaffield and 
Keeler 1993).
The structure-activity studies described above, though interesting basic science, were irrelevant to human health as 
jervanine alkaloids are not found at high levels in any food crops and the related solanidane and spirosolane 
alkaloids, which occur in potatoes, are considerably less teratogenic (Gaffield 2000). The information was also of 
little practical use to the veterinary community as the incidence of cyclopia in grazing animals dropped to near zero 
once livestock holders knew to keep newly pregnant animals away from fields containing V. californicum (Gaffield 
2000). Yet, the story of V. californicum and one-eyed sheep did not go unnoticed among researchers studying 
activation of the Hedgehog (Hh) signaling pathway during embryogenesis; a scientific happenstance with far-
reaching consequences for modern cancer treatment.
Of One-Eyed Sheep and Hedgehogs
In the late 1970s researchers Christiane Nüsslein-Volhard and Eric Wieschaus were studying embryonic pattern 
formation in Drosophilia melanogaster when they discovered a genetic locus they named hedgehog (hh), as the loss 
of function mutant produced a larvae covered in pointy denticles reminiscent of a hedgehog (the two would go on to 
win a Nobel prize in medicine in 1995 with Edward B. Lewis for their foundational work on the genetics of early 
development) (Nüsslein-Volhard and Wieschaus 1980). Research in the early 1990’s uncovered three homologous 
hedgehog genes in vertebrates: Sonic hedgehog (shh), Indian hedgehog (ihh), and Desert hedgehog (dhh). The 
proteins encoded by the aforementioned genes form concentration gradients in the embryo that direct aspects of 
cellular growth and differentiation during embryogenesis. Each hedgehog protein controls distinct developmental 
processes but the Sonic hedgehog protein (Shh) is the best studied, most widely expressed in the developing embryo, 
most potent, and directs the widest range of events. Additionally, all three hedgehog proteins undergo the same 
modifications and interact with the same cellular response elements (discussed below) and as such, the term Hh 
signaling will be used throughout the rest of this review although the majority of research in this area has dealt with 
Shh (Pathi et al. 2001; Varjosalo and Taipale 2008).
Shh protein is a morphogen requisite for the development of proper bilateral symmetry and dorsal ventral patterning; 
it also guides the formation of hands and feet, the central nervous system, and most epithelial tissues (Echelard et al. 
1993; Krauss et al. 1993; Riddle et al. 1993; Varjosalo and Taipale 2008). Sonic hedgehog loss of function mutants 
(shh-/-) develop holoprosencephaly (HPE) as the neural vesicle that gives rise to the optic nerves, optic chiasm, eyes, 
and pituitary gland fails to divide bilaterally (Cooper et al. 1998; Gaffield 2000). Notably, Shh is secreted as a 47-49
kDa pro-peptide that undergoes autolytic cleavage followed by palmitoylation at the N-terminus and covalent 
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addition of a molecule of cholesterol to the C-terminus of the resulting 19 kDa fragment to form the active peptide 
Shh-Np (Ihh and Dhh are similarly modified) (Porter et al. 1996; Pathi et al. 2001). Disorders of cholesterol 
biosynthesis impact shh signaling by impeding the formation of the active peptide and are often characterized by 
HPE (Cooper et al. 1998).
The mechanism of the Hh signaling begins with the stoichiometric binding of Shh-Np to the transmembrane 
transporter protein Patched (Ptch) (Marigo et al. 1996). Ptch, when not bound to Shh-Np, inhibits the seven-
transmembrane protein Smoothened (Smo), a G protein-coupled-like receptor. Upon binding of Shh-Np, this 
inhibition is lifted, activating a signaling cascade originating at Smo and culminating in the activation of the Gli 
family of zinc-finger transcription factors in vertebrates. The Gli transcription factors (particularly Gli-1 and Gli-2) 
up-regulate the transcription of Hh target genes, which enhance cellular proliferation and the epithelial-
mesenchymal transition (Ingham and McMahon 2001; Lum and Beachy 2004; Kasper et al. 2006; Kiesslich et al. 
2012).
Informed by the observation that jervine interfered with cholesterol metabolism, researchers at Johns Hopkins 
University School of Medicine demonstrated that jervine and cyclopamine, two jervanine alkaloids naturally 
occurring in North American Veratrum species, interfere with Hh signaling but do so without modifying the 
processing of Shh to Shh-Np (Beachy et al. 1997; Cooper et al. 1998). Furthermore, addition of exogenous Shh-Np
does not save Hh signaling from alkaloid-mediated inhibition (Cooper et al. 1998). Within a month, another group of 
researchers at the University of Washington published near identical results indicating that cyclopamine inhibited Hh 
signaling without disrupting the conversion of Shh to Shh- Np and did not interfere with cholesterol metabolism 
(Incardona et al. 1998). Both groups, noting that the transmembrane protein Ptch features a sterol-sensing domain, 
hypothesized that cyclopamine and jervine inhibited Hh signal transduction by interfering with Ptch’s ability to 
participate in intracellular cholesterol trafficking (Cooper et al. 1998; Incardona et al. 1998). However, later 
investigations revealed that cyclopamine antagonizes the Shh pathway by binding directly to Smo, Ptch’s 
downstream response element and does not interfere with cholesterol metabolism (Incardona et al. 2000; Taipale et 
al. 2000; Chen et al. 2002). Jervine has been found to bind in the same location, although with less affinity (EC50 of
500 nM vs 300 nM for cyclopamine), and there is evidence that the structurally similar alkaloids tomatidine, 
solasodine, and solanidine may act on Smo but are very weak inhibitors (Taipale et al. 2000; Lipinski et al. 2007; 
Stanton and Peng 2010). The discovery that cyclopamine inhibited Hh signal transduction provided developmental 
biologists examining early embryogenesis with a novel molecular probe that circumvented the need for gene 
knockout, but, more importantly, it identified a therapeutic target for diseases characterized by aberrant Hh signaling 
(Gaffield 2000).
Use of Veratrum Alkaloids in the Treatment of Aberrant Activity of the Hedgehog Signaling Pathway
The first major human disease linked to malfunctions in the Hh pathway was nevoid basal cell carcinoma syndrome 
(NBCCS, also Gorlin syndrome and basal cell nevus syndrome), an autosomal-dominant inherited condition. People 
with NBCCS suffer from myriad developmental irregularities including craniofacial malformations, spina bifida, 
and polydactylism and are highly susceptible to a range of tumors, especially those originating in the heart, ovaries, 
skin, and central nervous system. Yet, as the name suggests, the most common NBCCS tumor type is basal cell 
carcinoma (BCC). Individuals with NBCCS develop BCC lesions with increasing frequency in the second decade of 
life and the incidence of BCCs remains high throughout adulthood, requiring frequent surgical removal (Lo Muzio 
2008). This stands in contrast to BCC lesions that develop in fair skinned people later in life from cumulative 
exposure to UV light. While NBCCS is rare (prevalence of 1/57,000 to 1/256,000), BCC is the most common form 
of skin cancer (representing approximately 80% of non-melanoma skin cancers, lifetime incidence risk of 30% for 
people with light skin) and the incidence rate of this malignancy is rapidly increasing (Wong and Lear 2003; Rubin 
et al. 2005; Lo Muzio 2008; Rogers et al. 2010).
Research in the mid-1990s linked both inherited and de novo mutations in the gene coding for Ptch, a principal 
protein in the Hh signaling pathway, to NBCCS as well as sporadic BCC lesions (Gailani et al. 1996; Hahn et al. 
1996; Johnson et al. 1996; Wolter et al. 1997). These mutations caused inactive Ptch proteins, a result that explained 
many of the developmental malformations seen in NBCCS; Ptch genes are expressed by the sclerotome, spinal cord, 
and limbs during fetal development and are actively expressed in human skin during adulthood (Goodrich et al. 
1996; Marigo et al. 1996; Johnson et al. 1996). Building on this discovery, researchers also found activating 
mutations in genes coding for Smo in samples taken from sporadic BCC lesions (Xie et al. 1998). Similarly, genetic 
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investigations of primitive neuroectodermal tumors (PNETs), such as medulloblastoma, revealed high incidences of 
mutations in both Ptch and Smo (Raffel et al. 1997; Wolter et al. 1997; Reifenberger et al. 1998; Hahn et al. 1999; 
Zurawel et al. 2000). By the end of the decade, some estimated that up to 40% of sporadic BCCs and 25% of PNETs 
could have either loss of function mutations in Ptch or activating mutations in Smo, both of which cause the Hh 
pathway to be pathogenically over-expressed (Taipale et al. 2000). The growing link between mutations in the Hh 
signaling pathway and the development of certain cancers paved the way for targeted inhibition of the Hh pathway 
with small molecules, the first of which to be tested was the Veratrum alkaloid cyclopamine (Taipale et al. 2000).
Using a novel cell line sensitive to Shh-Np created from NIH 3T3 fibroblast cells transfected with Gli-Luc and TK-
Renilla reporters (Shh Light II cells), investigators Johns Hopkins University School of Medicine demonstrated that 
cyclopamine could inhibit activating oncogenic mutations in Ptch and Smo, preventing the spread of tumorigenic 
cells in vitro. These researchers also tested synthetic derivatives of cyclopamine, one of which, 3-keto N-aminoethyl 
aminocaproyl dihydrocin-namoyl cyclopamine (KAAD-cyclopamine), was 10-20 times more potent. The action of 
these small molecules indicated the target receptor was downstream of Ptch, possibly at the level of Smo (Taipale et 
al. 2000). Later work demonstrated definitively that cyclopamine binds directly to Smo, specifically to the 
transmembrane heptahelical bundle, and suggested that Ptch may regulate Smo through the controlled pumping of 
small, endogenous inhibitors (Chen et al. 2002; Incardona et al. 2002). The net result of the successful inhibition of 
the Hh signaling pathway with small, synthetic compounds was the instigation of pre-clinical trials assessing the 
utility of these molecules as therapeutic agents.
One of the first successful demonstrations of Hh antagonists as therapy came from a murine model of 
medulloblastoma, in which the administration of cyclopamine and KAAD-cyclopamine prevented growth of 
medulloblastoma cells in vitro and also caused shrinkage of tumor allografts in vivo. Additionally, cyclopamine and 
KAAD-cyclopamine caused rapid cell death in cultured human medulloblastoma cells in vitro (Berman et al. 2002). 
Subsequent studies using cyclopamine as a molecular probe demonstrated Hh pathway over-expression to be a 
factor in a murine model of BCC (Athar et al. 2004), pancreatic adenocarcinoma (Thayer et al. 2003), prostate 
cancer (Khardakar et al. 2004), small cell lung cancer (Watkins et al. 2003), cancers of the digestive tract (Berman et 
???? ??????? ?????????? ????? ????????? ??????? ???? ??????? ??????? ???????? ??? ???? ???????????? ??? ???? ???????????????????
signaling has been implicated in the pathogenesis of over twenty types of cancer (see Kar et al. 2012 for a current 
review). A full account of the intricacies of Hh signaling in cancer is outside the scope of this review but the 
emerging consensus is that Hh and other early embryonic signaling pathways (such as Notch and Wnt) are 
fundamental to the maintenance of so-called cancer stem cell (CSC) populations. CSCs are undifferentiated, self-
renewing cells within a tumor mass that are resistant to traditional chemotherapeutics (which target the rapidly 
dividing bulk tumor cells) and tend to be highly proliferative, likely leading to recurrence and metastasis of existing 
tumors (the reader is directed to the current review on the subject by Kiesslich et al. 2012).
As the list of tumor types sensitive to blockade of the Hh signaling pathway steadily grew, targeting the pathway 
emerged as an increasingly viable means of treating cancer (Rubin and de Sauvage 2006). The discovery and 
development of a wide range of synthetic and semi-synthetic Hh pathway antagonists followed, one of which, 
Genentech’s GDC-0449 (vismodegib) has passed through clinical trials and is now approved for use in the treatment 
of advanced metastatic BCC (Robarge et al. 2009; Sekulic et al. 2012; Tang et al. 2012; Pazdur 2012).  For more 
information on current small molecule antagonists and agonists of the Hh pathway, see the 2012 review by Yun and 
colleagues.
With the tremendous growth of research on the Hh pathway and cancer, it may be somewhat surprising that 
cyclopamine, the Veratrum alkaloid fundamental to early pre-clinical trials that established the field, is not being 
pursued as a pharmaceutical agent. However, the utility of cyclopamine as a therapeutic agent for cancer treatment is 
impeded by a number of molecular characteristics. First, cyclopamine is sparingly soluble (5 ?g/mL) in aqueous 
solutions (Yun et al. 2012). Second, the ether bridge formed by the spiro-connection at C-17 is acid labile, rendering 
the molecule biologically inactive if it passes through the stomach (Keeler 1970b; 1978; Wilson et al. 2010). Lastly, 
many synthetic Hh pathway antagonists display greater potency than cyclopamine; cyclopamine has an EC50 of 300 
nM, KAAD-cyclopamine has an IC50 of 20 nM, and GDC-0049’s has an IC50 of 13 nM (Rominger et al. 2009; 
Stanton and Peng 2010; Yun et al. 2012). Consequently, medicinal chemists have sought to modify and build on 
cyclopamine’s structure to improve its pharmacological attributes.
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Modifications to cyclopamine’s structure have included the addition of carbohydrate moieties to the piperidine ring 
nitrogen to improve aqueous solubility as well as the addition of prostate specific antigen and glucuronide at the 
same location to create prodrugs for the treatment of prostate cancer and glioblastoma respectively (Zhang et al. 
2008; Kumar et al. 2008; Hamon et al. 2010). A tartrate of cyclopamine has also been developed and this salt is 
readily soluble in aqueous solutions (Xie and Garrossian 2011). KAAD-cyclopamine is another example of 
substituent addition at the piperidine nitrogen and also features increased unsaturation in the A/B ring system. These 
modifications resulted in higher potency and aqueous solubility in comparison to cyclopamine, albeit the structure 
retains cyclopamine’s susceptibility to acidic conditions (Taipale et al. 2000; Tremblay et al. 2009). Perhaps the most 
notable cyclopamine derivative is the compound IPI-926 (saridegib) developed by Tremblay and colleagues at 
Infinity Pharmaceuticals (2008; 2009). This compound was created by expanding the D-ring of cyclopamine to 
create a heptacyclic configuration that minimizes the allylic effects of the oxygen atom in the E-ring, thus making it 
less acid labile, and adding a sulfonamide moiety to C-3 to improve aqueous solubility and potency (Tremblay et al. 
2009). IPI-926 demonstrated early promise; this drug advanced to a Phase 2 clinical trial in combination with 
gemcitabine for metastatic adenocarcinoma but the trial was stopped early when preliminary analysis revealed that 
median survival of patients in the treatment arm was less than that of the control arm (Infinity Pharmaceuticals 
2012a). Additionally, Infinity stopped Phase 2 trials of IPI-926 for the treatment of chondrosarcoma and 
myelofibrosis when the treatment arms failed to outperform placebo (Infinity Pharmaceuticals 2012b). A Phase 1 
trial of IPI-926 in combination with cetuximab for recurrent advanced head and neck cancers is in process 
(University of Colorado, Denver 2013).
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Appendix:
Table 1: Veratrum species of North America: Morphological features, range, habitat, and alkaloids
Species and 
Common Name
Morphological Features Range Habitat Alkaloids References
Veratrum viride
Green false hellebore
Up to 2 m tall when 
flowering; broad, pointed 
lower leaves; crowded 
paniculate inflorescences; 
generally features green 
perianths, lanceolate tepals; 
moderately hairy ovaries
Eastern North America 
from Quebec to Georgia; 
western North America 
from Alaska to 
California, inland to the 
mountainous regions of 
Montana, Idaho, and 
Alberta
Wet woods and moist 
coastal regions in 
Alaska and Quebec to 
mountain meadows in 
northern California, 
Idaho, Montana, and 
North Carolina
isorubijervine
germine
germitrine
germerine
veratramine
neogermitrine
rubivirine
jervine
isojervine
rubijervine
germidine
protoveratrine A&B
protoveratridine
neogermbudine
neogermidine
veramivirine 
pseudojervine
veratrosine
isorubijervosine
escholerine
desacetyl-protoveratrine
veratroylzygadenine
Kupchan 1961, 
Mathew 1989, Li et 
al. 2006, USDA 
NRCS 2013
Veratrum californicum 
var californicum
California false 
hellebore
1-2 m in height, broad lower 
leaves which continue up 
pseudostem; dark brown to 
black rhizome; crowded large 
inflorescences; creamy white 
tepals with glabrous ovaries
Washington, Oregon, 
Idaho, Montana, Utah, 
California, Nevada, New 
Mexico
Moist, sandy loam 
soils in subalpine 
meadows and forests, 
generally prefers north 
facing slopes which 
retain snow
cyclopamine 
cycloposine
dipotassium cevine
veratrosine
germine
isorubijervine
jervine
veratramine
rubijervine
muldamine
protoveratrine A & B
protoverine
pseudojervine
veracevine
Mathew 1989, 
Kupchan 1961, 
Keeler and Binns 
1966a, Keeler 1974*,
USDA NRCS 2013
Veratrum album
(includes ssp: V. 
lobelianum, V. 
oxysepalum, V. 
Grandiflorum
White false hellebore
Up to 2 m tall when 
flowering; paniculate 
inflorescences with very 
short perdicles (2-3 mm); 
often large, broad white 
tepals but local variations can 
include small green to white 
tepals, and even yellow 
Primarily Eurasia; 
Alaska
Damp mountain 
meadows
jervine
rubijervine
geralbine
germerine
germitrine
germitetrine
veratroylzygadenine
veralomidine
veralomine
veracintine
3-acetyl-15-
veratroylgermine
verdinine
veralobine
veralkamine
veralinine
veratrine
veratrobasine
veralbidine
veramanine
isojervine
verdine
veramine
germinaline
germinine
15-veratroylgermine
rhamnoveracintine
neojerminalanine
verussurine
methyljervine-N-3’-
propanoate veramarine
verazine
3,15-O,O’-(2-
methylbutyroyl)germine
veralodine
veralosine
protoveratrine A & B
germbudine
15,-O-(2-
methylbutyroyl)germine
pseudojervine
O-acetyljervine
isorubijervine
isorubijervosine
diacetylveralkamine
tetrahydroveralkamine
1-hydroxy-5,6-
dihydrojervine
jervinone
Kupchan 1961, 
Mathew 1989 Li et 
al. 2006, USDA 
NRCS 2013,
Veratrum fimbriatum
Fringed false hellebore
Heavily fringed green to 
white tepals; large nectaries; 
wingless, large seeds
Coastal northern 
California between Fort 
Bragg and Fort Ross
Coastal; sea level to 
several hundred meters 
in elevation, 5 km 
inland
jervine
pseudojervine
neogermitrine
Taylor 1956a, 
Mathew 1989, USDA 
NRCS 2013
Veratrum californicum 
var caudatum
Cascade false hellebore
Stem terminates in long, 
heavily flowered tail; large 
green-to-white perianths; 
glabrous ovaries
Western Oregon and 
Washington; north-
central Idaho
Lower elevation 
swampy meadows and 
coastal areas
NA, likely similar to 
var californicum
Kupchan 1961, 
Mathew 1989, USDA 
NRCS 2013
Veratrum tenuipetalum
Colorado false hellebore
Over 2 m tall when 
flowering; heavily flowered 
inflorescences; small white 
perianths
Colorado, Wyoming Moist openings and 
forest canopies, 
depleted riparian areas
NA, likely similar to 
V. californicum
Kupchan 1961, 
Mathew 1989,
Johnston 2002, 
USDA NRCS 2013
Veratrum insolitum
Siskiyou false hellebore
1 to 1.5 m tall; hairy upper 
pseudostem; very white-
wooly, paniculate 
inflorescences, heavily 
flowered with small yellow-
white perianths; densely 
wooly ovaries
Northern California, 
southwestern Oregon, 
Washington
Serpentine and diorite 
soils, wet openings in 
mixed-evergreen 
forests
NA Kupchan 1961, 
Mathew 1989, 
Washington Dept of 
Natural Resources 
2003, USDA NRCS 
2013
*Keeler R (1974) Isolation of rubijervine from Veratrum californicum. Phytochemistry 13:2336-2337
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Notes
1 Near the same time, researchers Saito and colleagues in Japan isolated the Veratrum alklaoids jervine and 
veratramine from V. grandiflorum, a member of the V. album complex (Saito and Suginome 1936, Saito 1940). 
Though not hypotensive Veratrum alkaloids, these compounds would be the subject of greater medical investigation 
in the 1960s and 1970s. See the section on teratogenic Veratrum alkaloids.
2 Seiferle et al. produced the first modern isolation of jervine, pseudojervine, rubijervine, protoveratridine, and 
germine from V. viride (Seiferle et al. 1942).
3 Notably, Kupchan and colleagues also isolated the alkamine germine from Zigadenus venenosus, further cementing 
the phytochemical relationship between the species of Veratrum and Zigadenus (Kupchan and Deliwala 1953).
4 The numerous permutations of cevanine ester-alkaloids with hypotensive qualities are substantial and the reader is 
directed to see the outstanding reviews by Kupchan (1961) and Krayer and Meilman (1977) for a more complete 
discussion of the phytochemistry and medical applications of these compounds respectively.
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Figure Captions
Figure 1: Geographic distribution of Veratrum species in North America. Emphasis is placed on species within 
Zomlefer et al.’s (2003) section Veratrum as these plants have been heavily investigated for the bioactive steroidal 
alkaloids they contain. Illustration adapted from distribution ranges in (Utech 2002) in Flora of North America, 
volume 26.
Figure 2: Steroidal alkaloids have been isolated from a wide range of plant and animal sources. Species of the genus 
Veratrum produce two broad classes of steroidal alkaloids: the Solanum alkaloids, which feature the classic 
cyclopentanophenanthrene ring structure and the Veratrum alkaloids, which feature a rearranged C-nor-D-
homosteroidal ring structure in the C-ring is five membered and the D-ring is six membered.
Figure 3: Biosynthetic pathway for steroidal alkaloids in Veratrum plants as elucidated by Kaneko and colleagues in 
V. grandiflorum. 3a: The nitrogen source for Veratrum alkaloids is likely L-arginine (Kaneko et al. 1976). 3b: Based 
on the observation that solanidine accumulates in etiolated plants and is then rapidly turned into Veratrum alkaloids 
featuring a C-nor-D-homosteroidal skeleton upon illumination, Kaneko et al. (1972, 1979) hypothesized that this 
conversion is light and energy dependent. 3c: Isolation of procevine suggests attack of the nitrogen atom on a 
suitable leaving group on C-18 precedes ring rearrangement in the formation of cevanine type alkaloids (Kaneko et 
al. 1978, 1979). 3d: Cyclopamine was found to be an intermediate compound from which veratramine and jervine 
can be formed (Kaneko et al. 1970a, b).
Figure 4: Cevanine alkamine bases. Esters of these bases reversibly bind to fast-sodium channels and lead to the 
Bezold-Jarisch reflex (hypotension, bradycardia, apnea) when injected into circulation.
Figure 5: Cyclopamine, cycloposine and jervine produce teratogenic effects in vertebrates by interfering with Hh 
signaling whereas the structurally similar and related alkaloids veratramine and tomatidine do not.
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